An Evidence for the Transcriptional Regulation of Iodothyronine Deiodinase 2 by Progesterone in Ovarectomized Rats

Overview

Journal J Physiol Biochem

Specialties Biochemistry
Physiology

Date 2013 Dec 24

PMID 24362948

Citations 1

Authors

Hossam A Awad

Zienab A Alrefaie

Affiliations

Soon will be listed here.

Abstract

Recent literature lacks studies on the effects of progesterone withdrawal on peripheral conversion of thyroxin (T4) into triiodothyronine (T3) by iodothyronine deiodinase 2 (D2) in different body tissues. The present study aimed to assess the possible relation of progesterone to T4, T3, and D2 in ovarectomized rats. Thirty female Wistar rats were included into a sham-operated control group and an ovarectomized group. Four months following the surgical procedures, measurements of estradiol, progesterone, free T4, free T3, and thyroid-stimulating hormone (TSH) were done. Also, estradiol/progesterone and T4/T3 ratios were calculated. Tissue homogenates from the kidney, liver, brain, thyroid, mandible, and femur were used to assess expression of D2 mRNA. The estradiol/progesterone ratio showed a significant increase in ovarectomized rats. T4 showed a significant increase in contrast to T3 which showed a highly significant decrease following ovariectomy. The T4/T3 ratio was significantly increased in ovarectomized rats. In addition, D2 expression was significantly attenuated in all tissue homogenates of the ovarectomized group. The present work showed a significant positive correlation between T4 and T3 in the sham-operated control rats, which was abolished in ovarectomized rats. A negative significant correlation between progesterone and T4 was revealed in ovarectomized rats. There was also a significant positive correlation between progesterone and D2 expression in the ovarectomized group. The results of the present study hypothesize that progesterone withdrawal may underlie the decrement in D2 expression, with consequent reduction in the peripheral conversion of T4 into T3 leading to a hypothyroid state.

Citing Articles

Region-specific effects of antenatal/early postnatal hypothyroidism on endothelial NO-pathway activity in systemic circulation.

Gaynullina D, Sofronova S, Selivanova E, Shvetsova A, Borzykh A, Tarasova O Curr Res Physiol. 2022; 5:8-15.

PMID: 34984343 PMC: 8692882. DOI: 10.1016/j.crphys.2021.12.002.

References

Pantaleao T, Mousovich F, Rosenthal D, Padron A, Carvalho D, Correa da Costa V . Effect of serum estradiol and leptin levels on thyroid function, food intake and body weight gain in female Wistar rats. Steroids. 2010; 75(10):638-42. DOI: 10.1016/j.steroids.2010.03.009. View

Pearce E . Thyroid dysfunction in perimenopausal and postmenopausal women. Menopause Int. 2007; 13(1):8-13. DOI: 10.1258/175404507780456746. View

Christoffolete M, Ribeiro R, Singru P, Fekete C, da Silva W, Gordon D . Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology. 2006; 147(4):1735-43. DOI: 10.1210/en.2005-1300. View

Schindler A . Thyroid function and postmenopause. Gynecol Endocrinol. 2003; 17(1):79-85. View

Kahaly G . Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 2000; 10(8):665-79. DOI: 10.1089/10507250050137743. View

Valencia M, Cordova Perez N, Zarate A, Basurto L, Apolinar L, Ruiz M . [Hypothyroidism associated to menopause symptoms worsening change with thyroid substitution therapy]. Ginecol Obstet Mex. 2008; 76(10):571-5. View

Badawy A, State O, Sherief S . Can thyroid dysfunction explicate severe menopausal symptoms?. J Obstet Gynaecol. 2007; 27(5):503-5. DOI: 10.1080/01443610701405812. View

Bianco A, Salvatore D, Gereben B, Berry M, Larsen P . Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002; 23(1):38-89. DOI: 10.1210/edrv.23.1.0455. View

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

10.

Nagata M, Suzuki A, Sekiguchi S, Ono Y, Nishiwaki-Yasuda K, Itoi T . Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women. Endocr J. 2007; 54(4):625-30. DOI: 10.1507/endocrj.k06-201. View

11.

Riese C, Michaelis M, Mentrup B, Gotz F, Kohrle J, Schweizer U . Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology. 2006; 147(12):5883-92. DOI: 10.1210/en.2006-0689. View

12.

Schneider M, Fiering S, Thai B, Wu S, Germain E, Parlow A . Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology. 2005; 147(1):580-9. DOI: 10.1210/en.2005-0739. View

13.

St Germain D, Galton V, Hernandez A . Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology. 2009; 150(3):1097-107. PMC: 2654746. DOI: 10.1210/en.2008-1588. View

14.

LEONARD J, Zuckerman C . Regulation of type II iodothyronine 5'-deiodinase by thyroid hormone. Inhibition of actin polymerization blocks enzyme inactivation in cAMP-stimulated glial cells. J Biol Chem. 1990; 265(2):940-6. View

15.

Wasco E, Martinez E, Grant K, St Germain E, St Germain D, Galton V . Determinants of iodothyronine deiodinase activities in rodent uterus. Endocrinology. 2003; 144(10):4253-61. DOI: 10.1210/en.2003-0490. View